Literature DB >> 11317696

Prognostic significance of recurrent chromosomal aberrations detected by comparative genomic hybridization in sporadic colorectal cancer.

P M De Angelis1, T Stokke, M Beigi, O Mjåland, O P Clausen.   

Abstract

Colorectal carcinomas are characterized by frequent recurrent gains and losses of chromosomal material, especially gains of chromosome arms 20q and 13q, and losses of chromosome arms 18q and 4q. These may be important in the development and progression of colorectal carcinomas. Chromosomal aberrations detected by comparative genomic hybridization in 67 sporadic colorectal carcinomas were examined for their possible associations with patient survival. Dukes' stage, tumor DNA ploidy status, and TP53 genotype/phenotype were also examined for the same. Patients with losses of chromosomal arms 1p, 4q, 8p, 14q, or 18q or gain of chromosomal arm 20q had significantly shorter survival times than those without these aberrations (univariate relative risk 3.45, 2.71, 3.32, 3.26, 3.32, 3.91, respectively), as did patients with more than six chromosomal aberrations per tumor than those with fewer than six aberrations (univariate relative risk 3.26, P = 0.013). DNA aneuploidy and Dukes' stage C + D resulted in poor patient survival (univariate relative risk 3.58, 3.39, respectively). Dukes' stage C + D, 1p loss and 8p loss emerged as the only independent prognostic parameters (relative risk 3.22, 2.53, 2.45, respectively) when entered into multivariate survival analysis together with other significant parameters from univariate survival analysis. Loss of chromosome arm 1p, 4q, 8p, 14q, or 18q or gain of chromosome arm 20q thus results in shortened survival times in colorectal cancer patients. 1p loss and 8p loss were shown to be independent predictors of poor prognosis.

Entities:  

Mesh:

Year:  2001        PMID: 11317696     DOI: 10.1007/s003840000275

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  11 in total

1.  Multiple genes identified as targets for 20q13.12-13.33 gain contributing to unfavorable clinical outcomes in patients with hepatocellular carcinoma.

Authors:  Dong Wang; Zhong-Zheng Zhu; Hongmei Jiang; Jiayi Zhu; Wen-Ming Cong; Bing-Ji Wen; Song-Qin He; Shu-Fang Liu
Journal:  Hepatol Int       Date:  2015-06-12       Impact factor: 6.047

2.  Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival.

Authors:  Ryan N Ptashkin; Carlos Pagan; Rona Yaeger; Sumit Middha; Jinru Shia; Kevin P O'Rourke; Michael F Berger; Lu Wang; Robert Cimera; Jiajing Wang; David S Klimstra; Leonard Saltz; Marc Ladanyi; Ahmet Zehir; Jaclyn F Hechtman
Journal:  Mol Cancer Res       Date:  2017-02-09       Impact factor: 5.852

3.  PDRG1, a novel tumor marker for multiple malignancies that is selectively regulated by genotoxic stress.

Authors:  Lingyan Jiang; Xiuquan Luo; Jingxue Shi; Hong Sun; Qing Sun; M Saeed Sheikh; Ying Huang
Journal:  Cancer Biol Ther       Date:  2011-03-15       Impact factor: 4.742

Review 4.  Gene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology.

Authors:  Manny D Bacolod; Francis Barany
Journal:  J Mol Diagn       Date:  2010-08-13       Impact factor: 5.568

5.  Reduced level of the spindle checkpoint protein BUB1B is associated with aneuploidy in colorectal cancers.

Authors:  E Burum-Auensen; P M DeAngelis; A R Schjølberg; J Røislien; O Mjåland; O P F Clausen
Journal:  Cell Prolif       Date:  2008-08       Impact factor: 6.831

6.  Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization.

Authors:  Ole Petter F Clausen; Hans Christian D Aass; Marzieh Beigi; Karin J Purdie; Charlotte M Proby; Victoria L Brown; Morten Mattingsdal; Francesca Micci; Steen Kølvraa; Lars Bolund; Paula M Deangelis
Journal:  J Invest Dermatol       Date:  2006-05-25       Impact factor: 8.551

7.  Deletion of chromosome 4q predicts outcome in stage II colon cancer patients.

Authors:  R P M Brosens; E J T H Belt; J C Haan; T E Buffart; B Carvalho; H Grabsch; P Quirke; M A Cuesta; A F Engel; B Ylstra; G A Meijer
Journal:  Cell Oncol (Dordr)       Date:  2011-06-30       Impact factor: 6.730

8.  Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients.

Authors:  Chieu B Diep; Manuel R Teixeira; Lin Thorstensen; Johan N Wiig; Mette Eknaes; Jahn M Nesland; Karl-Erik Giercksky; Bertil Johansson; Ragnhild A Lothe
Journal:  Mol Cancer       Date:  2004-02-23       Impact factor: 27.401

9.  Copy number alterations and allelic ratio in relation to recurrence of rectal cancer.

Authors:  Inès J Goossens-Beumer; Jan Oosting; Wim E Corver; Marjolein J F W Janssen; Bart Janssen; Wilbert van Workum; Eliane C M Zeestraten; Cornelis J H van de Velde; Hans Morreau; Peter J K Kuppen; Tom van Wezel
Journal:  BMC Genomics       Date:  2015-06-06       Impact factor: 3.969

10.  Tumor genome wide DNA alterations assessed by array CGH in patients with poor and excellent survival following operation for colorectal cancer.

Authors:  Kristina K Lagerstedt; Johan Staaf; Göran Jönsson; Elisabeth Hansson; Christina Lönnroth; Ulf Kressner; Lars Lindström; Svante Nordgren; Ake Borg; Kent Lundholm
Journal:  Cancer Inform       Date:  2007-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.